A Wearable Biosensor Patch for Non-Invasive Monitoring for Patients Undergoing Abdominal or Chest Surgery
NCT07612085 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2026-05-28
Summary
This clinical trial tests the feasibility and safety of a wearable biosensor patch for non-invasive monitoring for patients undergoing abdominal or chest surgery. Wearable biosensor patches have been developed by researchers to provide a non-invasive way to monitor substances that are normally checked using blood tests. This may reduce the need for frequent blood draws. The patches use gentle electrical stimulation to produce sweat and tiny built-in sensors to measure substances such as glucose, creatinine, and markers of inflammation, as well as oxygen and carbon dioxide levels. The wearable biosensor patch may be a feasible and safe way to monitor patients undergoing abdominal or chest surgery.
Conditions
- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm
Interventions
- PROCEDURE
-
Biospecimen Collection
Undergo sweat sample collection
- OTHER
-
Electronic Health Record Review
Ancillary studies
- OTHER
-
Interview
Ancillary studies
- OTHER
-
Survey Administration
Ancillary studies
- DEVICE
-
Wearable Biosensor Patch
Wear biosensor patch
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Kelly Mahuron · City of Hope Medical Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-02
- Primary Completion
- 2027-04-15
- Completion
- 2027-04-15
Countries
- United States
Study Locations
More Related Trials
-
Study of Neoadjuvant Chemotherapy of Breast Cancer
NCT00830544 ·Status: UNKNOWN ·Phase: PHASE2
-
Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer
NCT00005908 ·Status: COMPLETED ·Phase: PHASE2
-
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
NCT00436709 ·Status: UNKNOWN ·Phase: NA
-
AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer
NCT00310089 ·Status: COMPLETED ·Phase: NA
-
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
NCT03554044 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
NCT00256243 ·Status: COMPLETED ·Phase: PHASE2
-
Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes
NCT00007904 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
NCT01352494 ·Status: UNKNOWN ·Phase: PHASE2
-
TAC Versus TC for Adjuvant Breast Cancer
NCT00493870 ·Status: COMPLETED ·Phase: PHASE3
-
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
NCT00290732 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT01344109 ·Status: WITHDRAWN
-
Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients
NCT03164863 ·Status: UNKNOWN
-
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
NCT02003209 ·Status: COMPLETED ·Phase: PHASE3
-
"Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"
NCT01641406 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves
NCT05584163 ·Status: UNKNOWN ·Phase: NA
-
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)
NCT00499083 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
NCT00131963 ·Status: COMPLETED
-
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
NCT00003953 ·Status: COMPLETED ·Phase: PHASE2
-
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
NCT03155997 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Mobile Health for Adherence in Breast Cancer Patients
NCT06112613 ·Status: RECRUITING ·Phase: NA
-
Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast Cancer
NCT01019512 ·Status: TERMINATED ·Phase: NA
-
Nurse AMIE for Echo Show: Randomized Control Trial
NCT04673019 ·Status: COMPLETED ·Phase: NA
-
'ADVANCE' (A Pilot Trial)
NCT03858322 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Neoadjuvant Treatment of Breast Cancer
NCT00254592 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
NCT00044993 ·Status: COMPLETED ·Phase: PHASE2